Ataxia, Manifestation of Phenytoin Toxicity: A Case Report

  • Juhi S
  • Singh T
  • Manjeet Singh J
  • et al.
N/ACitations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Phenytoin is a choice of drug for the treatment of epilepsy. It is categorized under drugs with narrow therapeutic range. Adverse effects of phenytoin observed in patients are gum hypertrophy, dystonia, myoclonus, abnormal muscle movement and rarely ballismusand ataxia. We report a case of a 32-year-old female, who had chief complaints of ataxia, oscillopsia, dizziness and nausea. She had past medical history of epilepsy and was taking phenytoin from the past 10 years. Treatment was started after tapering the dose of phenytoin, finally discontinuing, she was prescribed with valproic acid as an alternative for phenytoin. Present case report describes the phenytoin toxicity that helps to create awareness among physicians. There should be proper monitoring of plasma concentration of phenytoin to avoid its toxicity in the patients on chronic drug therapy so that drug dosage can be tailored as per the pharmacokinetic needs of the patient.Copyright © 2019 EManuscript Technologies. All rights reserved.

Cite

CITATION STYLE

APA

Juhi, S., Singh, T. S., Manjeet Singh, J., Muhammed, R., Manik, C., & Kumar, T. R. (2018). Ataxia, Manifestation of Phenytoin Toxicity: A Case Report. Journal of Young Pharmacists, 11(1), 112–113. https://doi.org/10.5530/jyp.2019.11.24

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free